Figure 4.
Fetal measurements. GDM-STZ treated with Ganoderma lucidum. SC (0.9% saline solution), GDM+S (Diabetic+saline solution 0.9%), GDM+Glb (Diabetic + 100 mg/kg/day of Ganoderma lucidum from gestation day 1 to 19), GDM+Gla (Diabetic + 100 mg/kg/day of Ganoderma lucidum from gestation day 9 to 19). Data are presented as mean ± SD (n = 8). (*) p < 0.05 in comparison to SC group, (a) in comparison to the GDM+S group, (b) in comparison to the GDM+Glb group; One-way ANOVA, followed by Tukey–Kramer’s test.
